PURPOSE: Little is known about cancer survivors' receptivity to being contacted through cancer registries for research and health promotion efforts. We sought to (1) determine breast and colorectal cancer (CRC) survivors' responsiveness to a mailed survey using an academic medical center's cancer registry, (2) assess whether responsiveness varied according to sociodemographic characteristics and medical history, and (3) examine the prevalence and correlates of respondents' awareness and willingness to be contacted through the state cancer registry for future research studies. METHODS:Stage 0-III breast and CRC survivors diagnosed between January 2004 and December 2009 were identified from an academic medical center cancer registry. Survivors were mailed an invitation letter with an opt-out option, along with a survey assessing sociodemographic characteristics, medical history, and follow-up cancer care access and utilization. RESULTS:A total of 452 (31.4 %) breast and 53 (22.2 %) CRC survivors responded. Willingness to be contacted through the state cancer registry was high among both breast (74 %) and CRC (64 %) respondents even though few were aware of the registry and even fewer knew that their information was in the registry. In multivariable analyses, tumor stage I and not having a family history of cancer were associated with willingness among breast and CRC survivors, respectively. CONCLUSIONS: Our findings support the use of state cancer registries to contact survivors for participation in research studies. IMPLICATIONS FOR CANCER SURVIVORS: Survivors would benefit from partnerships between researchers and cancer registries that are focused on health promotion interventions.
RCT Entities:
PURPOSE: Little is known about cancer survivors' receptivity to being contacted through cancer registries for research and health promotion efforts. We sought to (1) determine breast and colorectal cancer (CRC) survivors' responsiveness to a mailed survey using an academic medical center's cancer registry, (2) assess whether responsiveness varied according to sociodemographic characteristics and medical history, and (3) examine the prevalence and correlates of respondents' awareness and willingness to be contacted through the state cancer registry for future research studies. METHODS: Stage 0-III breast and CRC survivors diagnosed between January 2004 and December 2009 were identified from an academic medical center cancer registry. Survivors were mailed an invitation letter with an opt-out option, along with a survey assessing sociodemographic characteristics, medical history, and follow-up cancer care access and utilization. RESULTS: A total of 452 (31.4 %) breast and 53 (22.2 %) CRC survivors responded. Willingness to be contacted through the state cancer registry was high among both breast (74 %) and CRC (64 %) respondents even though few were aware of the registry and even fewer knew that their information was in the registry. In multivariable analyses, tumor stage I and not having a family history of cancer were associated with willingness among breast and CRC survivors, respectively. CONCLUSIONS: Our findings support the use of state cancer registries to contact survivors for participation in research studies. IMPLICATIONS FOR CANCER SURVIVORS: Survivors would benefit from partnerships between researchers and cancer registries that are focused on health promotion interventions.
Authors: John M Salsman; Suzanne C Segerstrom; Emily H Brechting; Charles R Carlson; Michael A Andrykowski Journal: Psychooncology Date: 2009-01 Impact factor: 3.894
Authors: Shirley M Bluethmann; Caitlin C Murphy; Jasmin A Tiro; Michelle A Mollica; Sally W Vernon; Leona Kay Bartholomew Journal: Oncol Nurs Forum Date: 2017-05-01 Impact factor: 2.172
Authors: Heidi A Hamann; Jasmin A Tiro; Joanne M Sanders; Trisha V Melhado; Rachel K Funk; Melissa Y Carpentier; L Kay Bartholomew; Keith E Argenbright; Sally W Vernon Journal: J Cancer Surviv Date: 2013-08-23 Impact factor: 4.442
Authors: Anita Y Kinney; Rachel Howell; Rachel Ruckman; Jean A McDougall; Tawny W Boyce; Belinda Vicuña; Ji-Hyun Lee; Dolores D Guest; Randi Rycroft; Patricia A Valverde; Kristina M Gallegos; Angela Meisner; Charles L Wiggins; Antoinette Stroup; Lisa E Paddock; Scott T Walters Journal: Contemp Clin Trials Date: 2018-09-18 Impact factor: 2.226
Authors: Anita Y Kinney; Laurie E Steffen; Barbara H Brumbach; Wendy Kohlmann; Ruofei Du; Ji-Hyun Lee; Amanda Gammon; Karin Butler; Saundra S Buys; Antoinette M Stroup; Rebecca A Campo; Kristina G Flores; Jeanne S Mandelblatt; Marc D Schwartz Journal: J Clin Oncol Date: 2016-06-20 Impact factor: 44.544
Authors: David A Siegel; S Jane Henley; Jennifer M Wike; A Blythe Ryerson; Christopher J Johnson; Judy R Rees; Lori A Pollack Journal: Cancer Date: 2018-03-26 Impact factor: 6.860
Authors: Jasmin A Tiro; Joanne M Sanders; L Aubree Shay; Caitlin C Murphy; Heidi A Hamann; L Kay Bartholomew; Lara S Savas; Sally W Vernon Journal: Breast Cancer Res Treat Date: 2015-04-29 Impact factor: 4.872
Authors: Morgan M Millar; Anita Y Kinney; Nicola J Camp; Lisa A Cannon-Albright; Mia Hashibe; David F Penson; Anne C Kirchhoff; Deborah W Neklason; Alicia W Gilsenan; Gretchen S Dieck; Antoinette M Stroup; Sandra L Edwards; Carrie Bateman; Marjorie E Carter; Carol Sweeney Journal: Am J Epidemiol Date: 2019-05-01 Impact factor: 4.897
Authors: Elizabeth S Ver Hoeve; Leila Ali-Akbarian; Sarah N Price; Nurhyikmah M Lothfi; Heidi A Hamann Journal: Support Care Cancer Date: 2020-05-03 Impact factor: 3.359
Authors: Morgan M Millar; Joanne W Elena; Lisa Gallicchio; Sandra L Edwards; Marjorie E Carter; Kimberly A Herget; Carol Sweeney Journal: BMC Med Res Methodol Date: 2019-11-15 Impact factor: 4.615
Authors: Joseph Lipscomb; Cam Escoffery; Theresa W Gillespie; S Jane Henley; Robert A Smith; Toni Chociemski; Lyn Almon; Renjian Jiang; Xi Sheng; Michael Goodman; Kevin C Ward Journal: Int J Environ Res Public Health Date: 2020-02-04 Impact factor: 3.390